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Of the six major genotypes of hepatitis C virus (HCV), infectious cDNA clones of only genotype 1 have been reported. Here,
we report the construction of an infectious cDNA clone representing a second major HCV genotype, genotype 2. This
infectious clone (pJ6CF) encodes the consensus polyprotein of strain HC-J6CH, genotype 2a. Its encoded polyprotein differs
from those of the infectious clones of genotypes 1a and 1b by approximately 30%. Intertypic chimeric cDNA clones
constructed from infectious clones of genotypes 1a and 2a of HCV were not infectious. RNA transcripts of four chimeras
containing the 2a structural genes (C, E1, and E2) in the backbone of an infectious genotype 1a clone (pCV-H77C) were not
viable in a chimpanzee regardless of whether p7 was from the 1a or 2a clone. However, the chimpanzee was subsequently
infected with RNA transcripts of each of the two infectious parent clones, indicating that the inability of the chimeras to
replicate was intrinsic to the clones and not the result of preexisting protective immune responses.
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cINTRODUCTION
Hepatitis C virus (HCV) is a major causative agent of
hronic liver disease worldwide (Houghton, 1996). It has
ecently been estimated that more than 170 million peo-
le, about 3% of the world’s population, are chronically
nfected with HCV (WHO, 1997). These individuals are at
ncreased risk of developing chronic hepatitis, liver cir-
hosis, and hepatocellular carcinoma, as well as several
xtrahepatic diseases (Houghton, 1996). HCV is currently
he most common cause of liver transplantation due to
nd-stage liver disease (Hoofnagle, 1997). The only ef-
ective antiviral therapy for chronic hepatitis C, interferon
lone or in combination with ribavirin, induces a sus-
ained response in less than 50% of treated patients
Davis et al., 1998; McHutchison et al., 1998). Thus, there
s an urgent need for the development of a vaccine and
ore effective antiviral therapy, which will likely require a
etter understanding of the molecular biology and immu-
opathology of HCV.
HCV is a member of the genus Hepacivirus within the
laviviridae family of viruses (Rice, 1996). It has a posi-
ive-sense single-strand RNA genome approximately 9.6
1 The sequences reported in this paper have been deposited with the
enBank Database under Accession Nos. AF177036–AF177040.
2 Current address: Kahoku Central Hospital, Department of Internal
edicine, RO-104 Tsubata, Tsubata-cho, Kahoku-gun, Ishikawa 929-
323, Japan.
3 To whom correspondence and reprint requests should be ad-
ressed at NIH, NIAID, LID, Hepatitis Viruses Section, Building 7, Room
01, 7 Center Drive MSC 0740, Bethesda, MD 20892-0740. Fax: (301)i02-0524. E-mail: jbukh@niaid.nih.gov.
042-6822/99
250b in length. The single long open reading frame (ORF),
hich encodes a polyprotein of 3008–3033 amino acids,
s flanked by 59 and 39 untranslated regions (UTRs). The
9 UTR contains an internal ribosomal entry site (IRES;
emon and Honda, 1997). The 39 UTR consists of three
istinct regions: a short variable region, a polypyrimidine
ract of variable length, and a highly conserved terminal
egion of approximately 100 nts (Kolykhalov et al., 1996;
anaka et al., 1995, 1996; Yamada et al., 1996). The
olypyrimidine tract and the conserved region of the 39
TR are essential for infectivity in vivo (Yanagi et al.,
999). The ORF encodes a large polyprotein precursor
hat is co- and/or posttranslationaly processed by a com-
ination of host and viral proteases into at least 10
utative structural and nonstructural proteins (Rice,
996). The core protein (C) and two envelope glycopro-
eins (E1 and E2) are structural components of the virion.
he function of the p7 protein, which is cleaved ineffi-
iently from the C-terminus of E2, is not known and it is
till unclear whether p7 is a structural component of the
irion. The C, E1, E2, and p7 proteins are cleaved by host
ignal peptidases, whereas the cleavage of the putative
onstructural proteins (NS2, NS3, NS4A, NS4B, NS5A,
nd NS5B) is catalyzed by HCV-encoded proteases.
A remarkable characteristic of HCV is its genetic het-
rogeneity, which is manifested throughout the genome
Bukh et al., 1995). The most heterogeneous regions of
he genome are found in the envelope genes, in partic-
lar the hypervariable region 1 (HVR1) at the N-terminus
f E2 (Hijikata et al., 1991; Weiner et al., 1991). HCV
irculates as a quasispecies of closely related genomesn an infected individual. Globally, HCV isolates have
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251INFECTIOUS CLONE OF HCV GENOTYPE 2aeen classified into six major genetic groups (genotypes
–6) and multiple subtypes (subtypes 1a, 1b, 2a, 2b, 2c,
tc.) (Bukh et al., 1993; Robertson et al., 1998; Simmonds
t al., 1993). The nucleotide and deduced amino acid
equences among isolates within a quasispecies gen-
rally differ by ,2%, whereas those between isolates of
ifferent genotypes vary by as much as 35%. Genotypes
, 2, and 3 are found worldwide and constitute more than
0% of the HCV infections in North and South America,
urope, Russia, China, Japan, and Australia (Forns and
ukh, 1998). Throughout these regions genotype 1 ac-
ounts for the majority of HCV infections but each of
enotypes 2 and 3 accounts for 5–15%. A number of
tudies have suggested that HCV genotype status is
ssociated with the outcome of chronic HCV infection or
he response to interferon therapy (reviewed in Bukh et
l., 1997; Forns and Bukh, 1998). Patients infected with
enotype 1, and particularly subtype 1b, were reported to
ave more severe liver disease and to respond poorly to
nterferon therapy when compared to those infected with
enotypes 2 or 3. However, it is still not clear whether
hese differences are the result of epidemiological fac-
ors or of biological differences among HCV genotypes.
herefore, basic molecular studies are needed to define
nique virological features of HCV genotypes.
The synthesis of infectious cDNA clones of HCV ge-
otype 1a (Kolykhalov et al., 1997; Yanagi et al., 1997) has
ade it possible to study genomic structures, as well as
rotein sequences, of HCV by using recombinant DNA
echnology. Because there are no efficient in vitro prop-
gation systems for HCV, infectivity studies of molecular
lones of HCV must be performed by intrahepatic injec-
ion of RNA transcripts into chimpanzees, the sole animal
odel for HCV (Yanagi et al., 1998, 1999). These types of
tudies are limited by the cost and availability of chim-
anzees. However, in a previous mutagenesis study of
he 39 UTR of genotype 1a we demonstrated that several
utants could be tested consecutively in the same chim-
anzee (Yanagi et al., 1999).
Synthetic chimeric viruses can be used to map the
unctional regions of viruses with different phenotypes.
n flaviviruses and pestiviruses, infectious chimeric vi-
uses have been successfully engineered to express
ifferent functional units of related viruses (Bray and Lai,
991; Pletnev et al., 1992; Pletnev and Men, 1998; Vassi-
ev et al., 1997) and in some cases it has been possible
o make chimeras between nonrelated or distantly re-
ated viruses. For instance, the IRES element of poliovi-
us or bovine viral diarrhea virus has been replaced with
RES sequences from HCV (Frolov et al., 1998; Lu and
immer, 1996; Zhao et al., 1999). We recently showed
hat a viable chimera of two closely related HCV sub-
ypes could be constructed. The infectious chimera con-
ained the complete ORF of a genotype 1b strain but had
he 59 and 39 termini of a genotype 1a strain (Yanagi et al.,
998). It is important to determine whether chimeras eonstructed from more divergent HCV strains are infec-
ious because such chimeras could be used to define the
unctions of viral units and to dissect the immune re-
ponse. In the present study, we constructed a full-length
nfectious cDNA clone of HCV genotype 2a and at-
empted to construct infectious intertypic cDNA clones
hat encoded the structural proteins of the genotype 2a
lone in the backbone of an infectious genotype 1a
lone.
RESULTS
equence analysis of HCV strain HC-J6CH,
he genotype 2a cloning source
A plasma pool containing strain HC-J6CH was prepared
rom acute-phase plasmapheresis units collected from a
himpanzee experimentally infected with HC-J6 (Oka-
oto et al., 1991). The HCV genome titer of this pool was
05.4 genome copies/ml (Quantiplex HCV RNA bDNA 2.0,
hiron) and the infectivity titer was 104 chimpanzee in-
ectious doses/ml (Bukh et al., unpublished data).
The consensus sequence of the 59 UTR of HC-J6CH (nts
7–340) was deduced from five clones containing nts
7–297 and eight clones containing nts 86–340. The 59
TR of the various clones was highly conserved, but the
onsensus sequence of HC-J6CH differed by 2 nucleo-
ides from that published previously for HC-J6 (Okamoto
t al., 1991; C to T at position 36 and T to C at position
22).
The consensus sequence of 14 clones of the 39 UTR of
C-J6CH indicated that the 39-nucleotide-long variable
egion was highly conserved in this strain and was
dentical to that previously published for HC-J6 (Okamoto
t al., 1991). The polypyrimidine tract varied greatly in
ength (84–164 nucleotides) and contained some con-
erved A residues. In the conserved region, the proximal
6 nucleotides were identical to those previously pub-
ished for isolates of different HCV genotypes (Kolykha-
ov et al., 1996; Tanaka et al., 1996; Yamada et al., 1996).
he remaining 82 nucleotides of the conserved region
ere determined for other genotype 2a strains (Tanaka
t al., 1996) but not for HC-J6 or HC-J6CH.
The ORF of HC-J6CH was amplified in three fragments
y RT-PCR (Fig. 1). Eight clones of the J6S fragment (nts
6–2761), six clones of the J6B fragment (nts 2573–5488),
nd six clones of the J6A fragment (nts 5515–9298) were
equenced. PCR fragments containing nts 5489–5514
ere sequenced directly. A quasispecies was found at
43 nucleotide (2.7%) and 69 amino acid (2.3%) positions,
cattered throughout the 9099 nts (3033 aa) of the ORF.
owever, the majority, 231 nucleotide substitutions, were
etected only once and 71.6% of these represented silent
utations. The 12 remaining nucleotide substitutions
ere each restricted to two clones and only four of these
esulted in amino acid changes. The nucleotide differ-
nce among the J6S clones ranged from 0.1 to 1.3%,
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252 YANAGI ET AL.mong the J6B clones it ranged from 0.1 to 0.3%, and it
anged from 0.2 to 4.0% among the J6A clones (Fig. 2).
hree of eight J6S clones, four of six J6B clones, and all
ix J6A clones had defective polyproteins due to nucle-
tide deletions, insertions, or substitutions.
The sequences of clones of strain HC-J6CH were rela-
ively homogeneous. This was highlighted by the high
egree of conservation among clones of the HVR1 (Fig.
), a region frequently used to study the quasispecies of
CV (Bukh et al., 1995). An exception was the sequence
f clone J6A1, which differed by about 4% from the other
lones of this region (Fig. 2). Importantly, we could de-
ermine the consensus sequence of strain HC-J6CH (nts
7–9629) with no ambiguity at the nucleotide or deduced
mino acid level. The difference between the consensus
RF sequence of HC-J6CH from the experimentally in-
ected chimpanzee and that of HC-J6 of the inoculum
Okamoto et al., 1991) was 4.1 and 2.2% at the nucleotide
nd deduced amino acid levels, respectively (Fig. 2,
able 1). Moreover, we found that 12 (44.4%) of the 27
mino acids constituting HVR1 differed between HC-J6CH
nd HC-J6 (Fig. 3). Such diversities are greater than the
2% generally considered to comprise a quasispecies,
uggesting that each consensus sequence might repre-
ent a different strain of genotype 2a.
himeric molecular clones encoding genotype 2a
tructural proteins and genotype 1a nonstructural
roteins are not infectious in vivo
The consensus sequence of the 2a structural genes
nd surrounding region was substituted for that of the
nfectious 1a cDNA clone. In the genotype 1a backbone
e introduced two silent mutations for cloning purposes
at positions 2765 (p7) and 9158 (NS5B) of pCV-H77C]
Fig. 4). The complete sequence of each chimera was
erified. Infectivity of RNA transcripts from four different
FIG. 1. Amplification and cloning of hepatitis C virus, genotype 2a (
nfectious cDNA clone of HC-J6CH (pJ6CF). PCR products without primer
re indicated (number of clones sequenced are shown in parentheses).
he restriction enzymes used for cloning are indicated. An XbaI site inntertypic chimeric clones (Figs. 4 and 5) was evaluated ty consecutive intrahepatic transfections of a chimpan-
ee (Fig. 6). Clones were considered not to be viable if
iral RNA was not detected in the serum within 2 weeks
f the repeat transfection. All chimeric clones contained
he C, E1, and E2 genes of genotype 2a. The two chimeric
lones tested initially differed from each other in that one
ad the p7 gene of 2a (pH77CV-J6S) and the other
pH77(p7)CV-J6S] the p7 gene of 1a. They differed from
he two other clones in that the 186 nucleotides of the 59
TR just upstream of the initiation codon were from the
a genotype. Since neither clone containing the chimeric
9 UTR was infectious, the chimeric 59 UTR was replaced
ith the consensus genotype 1a 59 UTR to generate the
wo p7 varieties [pH77-J6S and pH77(p7)-J6S]. After con-
ecutive transfection of the four clones, we had not
etected HCV RNA, anti-HCV, or ALT elevation in the
himpanzee during 28 weeks of follow-up (Fig. 6), sug-
esting that RNA transcripts from these intertypic chi-
eric clones were not viable in vivo.
consensus molecular clone of genotype 2a is
nfectious in vivo
To prove that the genotype 2a portion used in the four
ntertypic chimeric cDNA clones indeed represented the
nfectious sequence, we constructed a consensus full-
ength cDNA clone of HC-J6CH (pJ6CF). The core se-
uence of the T7 promoter, a 59 guanosine residue, and
he full-length sequence of HC-J6CH (9711 nts) were
loned into pGEM-9Zf vector using NotI and XbaI sites.
ithin the HCV sequence there were no deduced amino
cid differences and only 4 nucleotide differences (at
ucleotide positions 1822, 5494, 9247, and 9289) from the
onsensus sequence of HC-J6CH as determined in the
resent study. The silent mutation at position 1822 was
ithin the structural region and so was also present in
he four intertypic chimeras. The 59 terminal 16 nts and
C-J6CH). The nucleotide positions correspond to the sequence of the
ces are shown. The names of the clones obtained from these products
mposition of the full-length cDNA clone (pJ6CF) is shown at the bottom.
CH was eliminated by a silent substitution at position 5494.strain H
sequen
The cohe 39 terminal 82 nts were deduced from previously
p
1
g
9
c
1
3
n
c
r
a
(
d
p
t
p
o
a
s
b
s
i
t
m
c
c
t
i
( ree ind
253INFECTIOUS CLONE OF HCV GENOTYPE 2aublished HCV genotype 2a sequences (Okamoto et al.,
991, Tanaka et al., 1996). The full-length cDNA clone of
enotype 2a contained a 59 UTR of 340 nts, an ORF of
099 nts encoding 3033 amino acids, and a 39 UTR
onsisting of a variable region of 39 nts followed by a
32-nucleotide-long polypyrimidine tract interrupted with
A residues and the 39 terminal conserved region of 98
ts.
RNA transcripts from pJ6CF were injected into the same
himpanzee used for injection of the four intertypic chime-
as (Fig. 6). The chimpanzee became infected at the first
ttempt with an HCV titer of 102 genome equivalents
3 4
FIG. 2. Tree analysis of clones amplified from an infectious acute-ph
ontaining strain HC-J6 (Okamoto et al., 1991). Also shown is a tree of th
lone (pJ6CF). The nucleotide positions with deletions or insertions we
ree analyses were performed with GeneWorks (Oxford Molecular Grou
ncluded in the analysis: HC-J8 (Okamoto et al., 1992), BEBE1 (Nakao et
Yanagi et al., 1998; genotype 1b infectious clone). The scale in each tGE)/ml at week 1 postinoculation (p.i.) and 10 –10 GE/ml guring weeks 2 to 6 p.i. The consensus sequence of PCR
roducts of the complete ORF, amplified from serum ob-
ained during week 5 p.i., was identical to the sequence of
J6CF and there was evidence of a quasispecies at only
ne position. There was no evidence of an anamnestic
ntibody response following infection with the 2a clone,
uggesting that the chimeric genomes had not replicated or
een translated to a significant extent. Since RNA tran-
cripts of this infectious genotype 2a clone were infectious
n vivo, and it shared an exact sequence with the noninfec-
ious intertypic chimeric clones, their failure to replicate
ust have been the result of incompatibilities between the
sma pool generated in a chimpanzee inoculated with human plasma
cted polyprotein sequence of HC-J6CH and the infectious HC-J6CH cDNA
ped in the analysis of the clones. Multiple sequence alignments and
h et al., 1995). Genotype designations are indicated. Other sequences
6), H77C (Yanagi et al., 1997; genotype 1a infectious clone), and J4L6S
icates the calculated genetic distance.ase pla
e predi
re strip
p) (Buk
al., 199enotype 1a and 2a sequences.
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254 YANAGI ET AL.To confirm that the chimpanzee used was susceptible
lso to infection by genotype 1a, which comprised most
f the intertypic chimeras, we subsequently inoculated
he chimpanzee with RNA transcripts from the infectious
enotype 1a clone (pCV-H77C) (Fig. 6). Serum samples
ere tested with J6-specific (genotype 2a) and H77-
pecific (genotype 1a) RT-PCR assays to identify super-
nfection with genotype 1a. At week 1 p.i. the total HCV
enome titer was 104 GE/ml, the J6-specific (2a) genome
iter was 104 GE/ml, and the H77-specific (1a) genome
iter was 102 GE/ml. The H77-specific genome titer in-
reased to 103 GE/ml at week 2 p.i. and reached 104
FIG. 3. Alignment of the hypervariable region 1 sequences from eigh
equence of the infectious plasma pool from an experimentally infecte
noculum (Okamoto et al., 1991).
TABLE 1
Percentage Difference of Nucleotide and Predicted Amino Acid
equences between Strain HC-J6 (Okamoto et al., 1991) and Strain
C-J6CH from Acute-Phase Plasma Pool of a Chimpanzee Inoculated
ith HC-J6
Genome region nt positiona % nt difference % aa difference
ORF 341–9439 4.1 (374/9099)b 2.2 (66/3033)b
59 UTR 17–340 0.6 (2/324)
Core 341–913 0.5 (3/573) 0 (0/191)
E1 914–1489 4.3 (25/576) 2.1 (4/192)
HVR1 1490–1570 24.7 (20/81) 44.4 (12/27)
E2-HVR1 1571–2590 3.9 (40/1020) 3.2 (11/340)
p7 2591–2779 3.7 (7/189) 3.2 (2/63)
NS2 2780–3430 4.0 (26/651) 2.8 (6/217)
NS3 3431–5323 4.1 (77/1893) 0.8 (5/631)
NS4A 5324–5485 4.3 (7/162) 1.9 (1/54)
NS4B 5486–6268 3.7 (29/783) 0.4 (1/261)
NS5A 6269–7666 5.4 (75/1398) 3.4 (16/466)
NS5B 7667–9439 3.7 (65/1773) 1.4 (8/591)
39 UTR 9440–9481 0 (0/42)
a The nucleotide positions correspond to those of the infectious
ull-length genotype 2a clone (pJ6CF).
b The numbers in parentheses indicate the nucleotide or amino acid
aifferences for each region.E/ml at week 3 p.i. The chimpanzee became chronically
nfected with genotype 1a (Fig. 6). The J6-specific (2a)
enome titer remained at 104 GE/ml at week 2 p.i., but
he 2a infection was apparently resolved during week
p.i. We confirmed that the consensus sequence of
elected PCR products amplified with H77-specific prim-
rs was identical to that of pCV-H77C and those ampli-
ied with J6-specific primers were identical to that of
J6CF. The chimpanzee seroconverted at week 15 fol-
owing superinfection with genotype 1a. The chimpanzee
ad normal serum liver enzyme values throughout fol-
ow-up. These experiments confirmed that the inability of
he intertypic 1a and 2a cDNA clones to infect the chim-
anzee was not the result of protective immune re-
ponses in the chimpanzee but represented deficiencies
ntrinsic to the chimeras.
DISCUSSION
The published infectious cDNA clones of HCV repre-
ent the two most important subtypes of genotype 1
Hong et al., 1999; Kolykhalov et al., 1997; Yanagi et al.,
997, 1998). However, five more major genotypes of HCV
re recognized. In the present study, we have demon-
trated the infectivity of a cDNA clone of a second major
CV genotype. As in previous studies, the infectivity of
NA transcripts was demonstrated in vivo by intrahe-
atic transfection of a chimpanzee. This new infectious
lone (pJ6CF) encodes the consensus polyprotein of
CV strain HC-J6CH, genotype 2a. Its encoded polypro-
ein differs from those of the infectious clones of geno-
ypes 1a and 1b by approximately 30% (Table 2). Geno-
ype 2 strains, in particular subtypes 2a and 2b, have a
orldwide distribution and important differences be-
ween genotypes 1 and 2 with respect to pathogenesis
nd treatment were indicated in previous studies. The
ones of strain HC-J6CH. HC-J6CH represents the consensus amino acid
panzee. HC-J6 is the published amino acid sequence of the originalt J6S cl
d chimvailability of an infectious clone representing a second
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255INFECTIOUS CLONE OF HCV GENOTYPE 2aajor genotype of HCV should permit new ways of study-
ng the molecular biology and immunopathology of this
mportant and genetically quite different human patho-
en.
We previously found that minor deviations from the
onsensus amino acid sequence rendered full-length
CV cDNA clones noninfectious (Yanagi et al., 1997,
998). Therefore, prior to constructing any full-length
lones we determined the consensus sequence of the
loning source of genotype 2a (strain HC-J6CH). The clon-
ng source was an acute-phase plasma pool from a
himpanzee that we had inoculated with plasma from a
atient chronically infected with strain HC-J6 (Okamoto
t al., 1991). We previously found it difficult to determine
he consensus sequence of other virus pools because of
equence heterogeneity (Yanagi et al., 1997, 1998). In
ontrast, the consensus sequence of the genotype 2a
ool could be determined without ambiguity. Among sev-
ral clones analyzed, only one was found to differ sig-
ificantly (Fig. 2). However, it should be noted that most
lones analyzed were defective for polyprotein synthesis
ue to insertions, deletions, or substitutions. Several of
hese mutations were observed in poly(C) or poly(G)
tretches in the genome. We believe that such mutations
ost likely represented errors introduced in the RT-PCR
nd cloning procedures (Forns et al., 1997), but they
ould also represent defective genomes since the infec-
ivity titer of the virus pool was 10-fold lower than the
enome titer. Surprisingly, the sequences recovered from
he chimpanzee (HC-J6CH) and those in the inoculum
HC-J6) differed by 4.1% at the nucleotide level and 2.2%
t the amino acid level (Table 1), which was a greater
ifference than generally detected in quasispecies. In
act, these differences are equivalent to those found
etween the two prototype strains of HCV genotype 1a
strains HCV-1 (Choo et al., 1991) and H77 (Yanagi et al.,
997)]. These results indicated that HC-J6CH, which rep-
FIG. 4. Construction of four intertypic chimeric cDNA clones. White b
equences derived from genotype 1a (pCV-H77C; Yanagi et al., 1997). W
nd induced an artificial NdeI site (mutation at position 2765 of pCV-Hesented the major species in the experimentally in- wected chimpanzee, was a minor species in the original
noculum.
The 59 and 39 UTRs of HCV are believed to be critical
or viral replication, translation, and viral packaging
Rice, 1996). The 59 203 terminal nucleotides and the 39
01 terminal nucleotides of the published infectious
lones of genotypes 1a and 1b were identical. However,
he sequences of UTRs of the genotype 2a clone differ
rom those of the genotype 1 clones. Overall, the 59 UTR
f the genotype 2a clone has 17 nt differences and a
ingle nucleotide deletion compared with the infectious
lones of genotype 1a (Fig. 5). Five of these differences
nd the deletion are within the first 30 nucleotides,
hereas the remainder are found within the predicted
RES structure. Differences also exist between the 39
TR of the genotype 2a clone and the clones of genotype
a (Fig. 5). The sequences of the variable region are very
ifferent. However, we recently demonstrated that this
egion is not critical for infectivity in vivo (Yanagi et al.,
999). Within the regions that are critical for infectivity in
ivo (Yanagi et al., 1999), the 132-nucleotide-long poly-
yrimidine tract of the genotype 2a clone has 3 unique A
esidues interspersed and the 39 terminal conserved
egion of 98 nts has 4 nt differences within the 39 termi-
al stable stem–loop structure (Fig. 5) (Kolykhalov et al.,
996; Tanaka et al., 1996). Since the 2a clone was infec-
ious, these sequence differences are apparently real
nd are compatible with infectivity. Further studies are
equired to determine whether these represent critical
enotype-specific sequences.
Experimental superinfection of chimpanzees with dif-
erent genotypes of HCV was previously reported to
esult in persistence of only one of the genotypes (Oka-
oto et al., 1994). In liver graft recipients only one HCV
enotype persists following superinfection; in cases
here genotype 1 is involved, this genotype is the one
hat persists (Laskus et al., 1996). In the present study,
re sequences derived from genotype 2a (pJ6CF) and black boxes are
inated an authentic NdeI site (mutation at position 9158 of pCV-H77C)
y site-directed mutagenesis; silent mutations are underlined.oxes a
e elime report the first HCV superinfection initiated by trans-
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256 YANAGI ET AL.ection with RNA transcripts from an infectious cDNA
lone; hence, a chimpanzee infected with monoclonal
FIG. 5. Alignment of the nucleotide sequences of the 59 and 39 UTR
a chimeric cDNA clones. In the 59 UTR alignment we included the fir
onda, 1997). Top line: the sequence of the infectious genotype 1a clon
enotype 2a clone (pJ6CF). Dot: identity with the sequence of H77C. C
nitiation or stop codon of the ORF. Underlined: AgeI cleavage site. Arr
umbering corresponds to the sequence of pCV-H77C.enotype 2a was superinfected with monoclonal geno- wype 1a. The genotype 2a infection was apparently
leared within 3 weeks following superinfection,
he amino acid sequences of E2/p7/NS2 junctions in the intertypic 1a,
ts of core believed to be important for the IRES function (Lemon and
-H77C; Yanagi et al., 1997). Bottom line: the sequence of the infectious
letter: different from the sequence of H77C. Dash: deletion. Boldface:
tative sites in the HCV polyprotein cleaved by host signal peptidases.s and t
st 39 n
e (pCV
apital
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257INFECTIOUS CLONE OF HCV GENOTYPE 2aule out the possibility that the 2a infection was cleared
ue to an immune response mounted to the acute 2a
nfection. However, the chimpanzee did not develop HCV
ntibodies until 15 weeks after the superinfection with
FIG. 6. Consecutive intrahepatic transfections of chimpanzee 1564 w
f HCV and the parent genotype 2a (pJ6CF) and genotype 1a (pCV-H77C
a clone was viable. The chimpanzee was superinfected following t
T-nested PCR for HCV RNA (1, positive; 2, negative) and of the seco
erum levels of alanine aminotransferase (ALT, shaded area) and the lo
nd 2a, vertical columns; Amplicor HCV Monitor 2.0 for total HCV RNA,
f the Monitor test at weeks 29 and 44 (no titer shown).
TABLE 2
Percentage Difference of the Amino Acid Sequences between the
nfectious Clone of Genotype 1a (pCV-H77C; Yanagi et al., 1997) and
he Infectious Clone of Genotype 2a (pJ6CF) of Hepatitis C Virus
Genome regiona % difference
Polyprotein 27.9 (839/3007)b
Core 8.9 (17/191)
E1 37.0 (71/192)
HVR1 59.3 (16/27)
E2-HVR1 27.1 (91/336)
p7 38.1 (24/63)
NS2 41.9 (91/217)
NS3 19.2 (121/631)
NS4A 33.3 (18/54)
NS4B 26.8 (70/261)
NS5A 38.5 (171/444)
NS5B 25.2 (149/591)
a Genome regions defined as in Table 1.
b The numbers in parentheses indicate the amino acid differences
or each region. Positions with deletions or insertions in E2 (4 aa
cositions) and NS5A (26 aa positions) were not considered.enotype 1a. The replacement of one genotype by an-
ther indicates that there may be important biological
ifferences among the genotypes and emphasizes the
eed to study viruses representing each of the major
enotypes of HCV.
Chimeric flaviviruses with substituted structural genes
ave been useful in defining the biological function of
iral sequences or proteins, in analyzing immune re-
ponses, and in generating attenuated vaccine candi-
ates (Bray and Lai, 1991; Chambers et al., 1999; Pletnev
t al., 1992, 1993; Pletnev and Men, 1998). The original
oal of the present study was to construct a similar
nfectious intertypic chimeric cDNA clone between two
ajor genotypes of HCV. However, we found that RNA
ranscripts of chimeras containing the structural genes
C, E1, and E2) with or without p7 from the infectious
enotype 2a clone (pJ6CF) and the nonstructural genes
f an infectious genotype 1a clone (pCV-H77C) were not
iable in vivo.
Considerable sequence variation exists between the
nfectious genotype 1a and 2a clones of HCV (Table 2).
et, we were somewhat surprised to find that the inter-
ypic clones between genotypes 1a and 2a were not
iable since flavivirus chimeras containing the structural
egion of dengue virus type 1 or 2 or of tick-borne en-
A transcripts of four genotype 1a and 2a intertypic chimeric genomes
s. The four intertypic chimeras were nonviable, whereas the genotype
tion with an infectious clone of genotype 1a. Results of qualitative
eration ELISA test for anti-HCV (1, positive; 2, negative) are shown.
V genome equivalent titer (in-house RT-PCR specific for genotypes 1a
were plotted against time. The HCV titer was below the detection limitith RN
) clone
ransfec
nd-gen
g10 HC
circles)ephalitis virus and the nonstructural region of an infec-
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258 YANAGI ET AL.ious dengue type 4 virus were viable (Bray and Lai, 1991;
letnev et al., 1992, 1993). These viruses exhibit a higher
egree of genetic heterogeneity than do the major geno-
ypes of HCV. For other flaviviruses, however, it was
ossible to obtain infectious chimeric clones only if the
apsid region was derived from the backbone cDNA
lone (Chambers et al., 1999; Pletnev and Men, 1998).
Trivial explanations may account for the lack of viabil-
ty of our intertypic chimeras. First, the two silent muta-
ions introduced in the genotype 1a backbone (one in p7
nd one in NS5B) for cloning purposes could potentially
liminate infectivity. This is, however, very unlikely since
utations at these positions exist among field isolates of
CV including strain HC-J6CH (Bukh et al., 1998). Also, it
s noteworthy that the three previously published infec-
ious clones of strain H77 had numerous silent nucleo-
ide differences (Hong et al., 1999; Kolykhalov et al., 1997;
anagi et al., 1997). Second, signal peptidases might not
leave the chimeric E2/p7 or p7/NS2 junction. This
eems unlikely, however, since eukaryotic signal pepti-
ases typically recognize the amino acid sequences
pstream of the cleavage site [the (23, 21) rule]
Nielsen et al., 1997) and the amino acids at these two
ites are conserved between genotypes 1a and 2a (Fig.
). Finally, the E2/p7 and/or p7/NS2 gene junctions could
iffer between genotypes 1a and 2a. We used the junc-
ions determined for genotypes 1a and 1b (Lin et al.,
994; Mizushima et al., 1994; Selby et al., 1994) because
hose for genotype 2a have not been identified. In the
atter two cases, further analyses of genotype 2a should
ventually provide sufficient data to overcome such po-
ential problems and it would most likely be possible to
onstruct a viable chimera.
More complicated explanations for the lack of viability
f the chimeras might be required if critical genotype-
pecific interactions occur as regards the structural pro-
eins, the nonstructural proteins, and the genomic RNA.
or instance, we cannot rule out the possibility that the
himeras were not viable because the IRES function was
ompromised. In in vitro studies the IRES activity de-
ended on RNA sequences not only in the 59 UTR but
lso extending 39 of the translation initiation site (Hahm
t al., 1998; Lemon and Honda, 1997; Reynolds et al.,
995). Although the 39 border of the HCV IRES is still
ontroversial it is believed to involve at most the first 39
ts of the core gene (Lemon and Honda, 1997). The 59
TR of the intertypic chimeras was a chimera of geno-
ype 1a and 2a sequences or the entire 59 UTR was
erived from the 1a clone (Figs. 4 and 5). Importantly, the
9 end of core is conserved among genotypes 1a and 2a
Fig. 5). Thus, the predicted IRES-like secondary struc-
ure is maintained in our chimeras, suggesting that the
RES activity most likely was maintained.
Possible interactions between the structural proteins,
he nonstructural proteins, and the genomic RNA, which
nvolve RNA packaging, replication, or translation, are Ponceivable. In poliovirus, which is another positive-
ense RNA virus, functional coupling of RNA packaging
o RNA replication and of RNA replication to translation
as been suggested (Novak and Kirkegaard, 1994; Nu-
ent et al., 1999). Similar to other viruses of the Flaviviri-
ae family, a membrane-associated replicase complex is
hought to initiate replication at the 39 end of HCV and to
ynthesize a complementary negative-strand RNA (Rice,
996). The putative cis-acting elements at the 59 and 39
ermini, which are believed to be important for viral
enome replication (Rice, 1996; Frolov et al., 1998),
hould be maintained in the intertypic HCV chimeras at
east in the two constructs with the authentic 1a 59 UTR.
owever, it is conceivable that the viral packaging sys-
em was interrupted (Frolov et al., 1998). Studies using a
unjin flavivirus replicon system and providing the struc-
ural proteins in trans suggested that the essential en-
apsidation signals did not reside in the structural region
f the genome (Khromykh et al., 1997, 1998). The location
f the packaging signals of HCV is not known. However,
f the structural proteins encapsidate viral RNA via gen-
type-specific sequences outside of the structural re-
ion, the chimeras would be unable to package the RNA
nd it might be extremely difficult to construct viable
himeras between highly divergent strains.
In summary, an infectious cDNA clone of a second
ajor genotype of HCV (genotype 2a) is now available.
he fact that four intertypic chimeric HCV cDNAs encod-
ng the structural proteins from this infectious genotype
a clone in the backbone of an infectious genotype 1a
lone were not viable in vivo indicates that there are
any basic questions about HCV that remain to be
nswered. A detailed analysis of genotype 2a should be
acilitated by the use of this cDNA clone and should
ventually provide information about which characteris-
ics of genotype 1 also apply to genotype 2.
MATERIALS AND METHODS
ource of HCV
An infectious plasma pool of HCV genotype 2a (HC-
6CH) was prepared from acute-phase plasma of a chim-
anzee experimentally inoculated with plasma from a
apanese patient infected with strain HC-J6 (Okamoto et
l., 1991). This was used for cloning. We also used an
nfectious cDNA clone of HCV strain H77, genotype 1a
pCV-H77C; Yanagi et al., 1997).
mplification, cloning, and sequence analysis
f strain HC-J6, genotype 2a
Viral RNA was extracted from 100-ml aliquots of the
C-J6CH plasma pool with the TRIzol system (Gibco BRL)
Yanagi et al., 1997). Primers used in cDNA synthesis and
CR amplification were based on the genomic sequence
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259INFECTIOUS CLONE OF HCV GENOTYPE 2af strain HC-J6 (Okamoto et al., 1991) and from the con-
erved region (39X) of the 39 UTR of HCV genotype 2a
Tanaka et al., 1996) (Table 3). The RNA was denatured at
5°C for 2 min, and cDNA was synthesized at 42°C for
h with Superscript II reverse transcriptase (Gibco BRL)
nd specific reverse primers in 20-ml reaction volumes.
he cDNA mixtures were treated with RNase H and
Nase T1 (Gibco BRL) at 37°C for 20 min.
The strategy used to amplify and clone the full-length
C-J6CH sequence is shown in Fig. 1. Nucleotide posi-
ions correspond to those of the 2a infectious clone
pJ6CF) that is reported in this paper. The 59 end of
C-J6CH (nts 17–297, excluding primer sequences) was
mplified from 2 ml of cDNA synthesized with primer a-2
Yanagi et al., 1996). PCR was performed with AmpliTaq
old DNA polymerase (Perkin–Elmer) as described pre-
iously (Yanagi et al., 1996) using primers 1S-J6F and a-2.
T
Hepatitis C Virus Genotypes 1a and 2a: Oligonucleot
and for Diagnostic
Designation
427S-H77 ACTGGACACGGAGGTGGCCGCGTC
462S-H77 TTGTTCTTGTCGGGTTAATGGCGC
645R-H77 GGGTGTACTACACACATGAGTAAG
832R-H77 AAGCGCCCCTAACTTGATGATG
439S-J6 TTATGACGCATCTGTGCATGGCCA
474S-J6 CTCTGCTGGTAATGATCACTCTCT
844R-J6 CCACCTGCCAAGGGCTAGTAGC
657R-J6 GGGTAGAATATGGCGACGGCCCAT
2751SII CGTCATCGATACCTCAGCGGGCATATGCA
2786R GTCCAGTGCATATGCCCGCTGAGG
2870R CATGCACCAGCTGATATAGCGCTTGTAATA
7851S TCCGTAGAGGAAGCTTGCAGCCTGACGCC
9140S (M) CAGAGGAGGCAGGGCTGCTATATGTGGCA
9173R (M) GTACTTGCCACATATAGCAGCCCTGCCTCC
9417R CGTCTCTAGACAGGAAATGGCTTAAGAGGC
6-H2556S TTATGGATGCTCATCTTGTTGGGCCAGGCC
56RF-J6H AGGATTTGTGCTCATGGTGCACGGTCTACG
S-J6Fb TTTTTTTTGCGGCCGCTAATACGACTCACTA
33S-J6 CCGTGCACCATGAGCACAAATCCTAAACCT
53R-J6 GGATGTACCCCATGAGGTCGGCAAAG
543S-J6F GTTTGCGCCTGCTTATGGATGCTCATCTTG
787R-J6 GCGTCATAAGCATATGCCTGTTGGGG
329R-J6 CCCTCAGCACTGGAGTACATCTG
487S-J6F CGTCATGCATACCCCTAGGGCGGCTCTCA
518R-J6F CTGCCCCTCTTCAATGAGAGCCGCTCTAGA
251S-J6F GCGGTGAAGACCAAGCTCAAACTCACTC
310R-J6F CGTCTCTAGAGGATAAATCCAGGAGGCGC
399S-J6F TACTTTTTGTAGGGGTAGGCCTTTTCC
464R-J6F CGTCTCTAGAGTGTAGCTAATGTGTGCCGC
470R (24)-J6F CTATGGAGTGTAGCTAATGTGTGC
6-39XR CGTCTCTAGACATGATCTGCAGAGAGACCA
GTGACTAGGGCTAAGATGGAGCCACC
a HCV-specific sequences are shown in plain text, non-HCV-specific
re underlined.
b The core sequence of the T7 promoter is shown in italics.fter purification, the amplified products were cloned bnto pGEM-T Easy vector (Promega) using standard pro-
edures and five clones (pJ6-59UTR) were sequenced.
The 39 end of HC-J6CH was amplified in three overlapping
ieces. RT-PCR of a short fragment of NS5B (nts 9279–
439) was performed with primers 9251S-J6F and 9464R-
6F as described above. The PCR products were cloned
nto pGEM-T Easy vector and sequence analysis was per-
ormed from five pJ6-39F clones. A second region spanning
rom NS5B to the conserved region of the 39 UTR (nts
376–9629) was amplified in RT-nested PCR (external prim-
rs H9261F and H39X58R, internal primers H9282F and
39X45R) (Yanagi et al., 1997). The amplified products were
loned into pGEM-9zf(2) by using HindIII and XbaI sites
nd 14 pJ6-39VR clones were sequenced. The third frag-
ent, which included the 39 terminal sequence, was am-
lified with primers 9399S-J6F and J6-39XR from one of the
J6-39VR clones and cloned into one of the pJ6-39F clones
sed for cDNA Synthesis, Amplification, and Cloning,
sted PCR Assays
equence (59 3 39)a
CACGGA
GTGTTTACC
AGCTTTGGAGAACCTCGTAATACTCAATGC
CCCGCCCCTAATAGG
GAGGG
CGGC
GGCACTCTCTGCAGTCATGCGGCTCACGGACCTTTCACAGCTAGCC
ces are shown in boldface, and cleavage sites used for cDNA cloningABLE 3
ides U
RT-ne
S
CTGGA
TG
C
AGTAC
TCTG
CGGA
GAAGC
AG
TAGA
C
TTGAA
GCTTC
TCTA
GTTAC
sequeny using StuI and XbaI sites (pJ6-39X).
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260 YANAGI ET AL.The ORF of HCV HC-J6CH was amplified by long RT-
CR in three overlapping pieces. The amplification was
erformed on 2 ml of the cDNA mixtures with the Advan-
age cDNA polymerase mix (Clontech) (Yanagi et al.,
997). The J6S fragment (nts 86–2761) was amplified with
rimers a-1 (Yanagi et al., 1996) and 2787R-J6 from cDNA
ynthesized with primer 3329R-J6. A single PCR round
as performed in a Robocycler thermal cycler (Strat-
gene) and consisted of denaturation at 99°C for 35 s,
nnealing at 67°C for 30 s, and elongation at 68°C for 4
in 30 s during the first 5 cycles, 5 min during the next
0 cycles, 5 min 30 s during the following 10 cycles, and
min during the last 10 cycles. The J6B fragment (nts
573–5488) was amplified with primers 2543S-J6F and
518R-J6F from cDNA synthesized with primer 5518R-J6F.
inally, the J6A fragment (nts 5515–9282) was amplified
ith primers 5487S-J6F and 9310R-J6F from cDNA syn-
hesized with primer 9470R(24)-J6F. PCR amplifications of
ragments J6B and J6A consisted of denaturation at 99°C
or 35 s, annealing at 67°C for 30 s, and elongation at
8°C for 6 min during the first 5 cycles, 7 min during the
ext 10 cycles, 8 min during the following 10 cycles, and
min during the last 10 cycles.
After purification of the long PCR products with the
IAquick PCR purification kit (Qiagen), A-tailing reac-
ions were performed with AmpliTaq DNA polymerase
Perkin–Elmer) at 72°C for 1 h. The gel-purified A-tailed
CR products were cloned into pCR2.1 vector (Invitrogen)
r pGEM-T Easy vector (Promega). DH5-a competent
ells (Gibco BRL) were transformed and selected on LB
gar plates containing 100 mg/ml ampicillin (Sigma) and
mplified in LB liquid cultures at 30°C for 18–20 h (Yanagi
t al., 1997). Midiprep was performed using Wizard Plus
idipreps DNA Purification System (Promega). Multiple
lones of the J6S, J6A, and J6B fragments were se-
uenced.
We determined the consensus sequence of strain HC-
6CH (nts 17–9629) by direct sequencing of PCR products
nts 297–3004 and nts 4893–5762) and by sequence
nalysis of the TA clones (nts 17–5488 and nts 5515–
629) (Fig. 1). Both strands of DNA were sequenced in all
ases. Analyses of genomic sequences, including mul-
iple sequence alignments and tree analyses, were per-
ormed with GeneWorks (Oxford Molecular Group) (Bukh
t al., 1995).
onstruction of intertypic chimeric cDNA clones
f genotypes 1a and 2a
We constructed four full-length intertypic chimeric
DNA clones (Figs. 4 and 5). In each clone the C, E1, and
2 genes encoded the consensus amino acid sequence
f HC-J6CH. The p7 protein was encoded either by the
C-J6CH or by the pCV-H77C consensus sequence, and
he NS proteins were all encoded by pCV-H77C genes.
o engineer these cDNA clones, we first eliminated an sdeI site from pCV-H77C by a silent substitution (C to T)
t position 9158. In brief, two fragments were amplified
rom pCV-H77C with primers H7851S and H9173R(M) and
ith primers H9140S(M) and H9417R (Table 3), gel-puri-
ied, and used for fusion PCR with primers H7851S and
9417R. The fusion PCR products were cloned into pCV-
77C by using HindIII and AflII sites. A new artificial
deI site was introduced by a silent substitution (C to T)
t position 2765. PCR products, which were amplified
rom pCV-H77C with primer H2751SII containing artificial
laI and NdeI sites and primer H2870R, were cloned into
he modified pCV-H77C by using ClaI and Eco47III sites.
he final construct (pH77CV) was used as a cassette
ector to construct the intertypic chimeric HCV cDNA
lones.
The four chimeric cDNA clones were constructed as
ollows. For pH77CV-J6S, the AgeI/BsmI fragment of
lone J6S2 and the BsmI/NdeI fragment of clone J6S1
ere cloned into pH77CV by using AgeI and NdeI sites.
or pH77(p7)CV-J6S, a fragment of pH77CV-J6S was re-
laced with a fragment amplified from pCV-H77C with
rimers J6-H2556S and H2786R by using BsaBI and NdeI
ites. For pH77-J6S, a fragment amplified from pCV-H77C
ith primers a-1 and 356RF-J6H and another fragment
mplified from pH77CV-J6S with primers 333S-J6 and
53R-J6 were gel-purified and a fusion-PCR was per-
ormed with primers a-1 and 753R-J6. The AgeI/ClaI frag-
ent of the subcloned fusion PCR products and the
laI/NdeI fragment of pH77CV-J6S were cloned into
H77CV-J6S by using AgeI and NdeI sites. For pH77(p7)-
6S, the AgeI/ClaI fragment of pH77-J6S and the ClaI/
deI fragment of pH77(p7)CV-J6S were cloned into
H77(p7)CV-J6S by using AgeI and NdeI sites.
Each intertypic chimeric cDNA clone was retrans-
ormed to select a single clone, and large-scale prepa-
ation of plasmid DNA was performed with a Qiagen
lasmid Maxi kit as described previously (Yanagi et al.,
997). Each of the four cDNA clones was completely
equenced before inoculation. Each clone was geneti-
ally stable since the digestion pattern was as expected
ollowing retransformation and the complete sequence
as the expected one.
onstruction of authentic full-length consensus cDNA
lone of strain HC-J6CH, genotype 2a
An overview of the full-length HC-J6CH clone is pre-
ented in Fig. 1. In the final construct pJ6CF, which
ncodes the consensus polyprotein of HC-J6CH, an XbaI
ite was eliminated by a silent substitution (A to G) at
osition 5494. Digested fragments containing the con-
ensus sequence were purified from the appropriate
ubclones and ligated using the sites indicated. The
ull-length cDNA clone (pJ6CF) was retransformed to
elect a single clone, and large-scale preparation of
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261INFECTIOUS CLONE OF HCV GENOTYPE 2alasmid DNA followed by the complete sequence anal-
sis was performed. Clone pJ6CF was genetically stable.
ntrahepatic transfection of a chimpanzee
ith transcribed RNA
In duplicate 100-ml reactions, RNA was transcribed in
itro with T7 RNA polymerase (Promega) from 10 mg of
emplate plasmid linearized with XbaI (Promega) as de-
cribed previously (Yanagi et al., 1997). The integrity of
he RNA was checked by electrophoresis through aga-
ose gel stained with ethidium bromide (Yanagi et al.,
997). Each transcription mixture was diluted with 400 ml
f ice-cold phosphate-buffered saline without calcium or
agnesium and then immediately frozen on dry ice and
tored at 280°C. Within 24 h, both transcription mixtures
ere injected into the same chimpanzee by percutane-
us intrahepatic injection guided by ultrasound (Yanagi
t al., 1998, 1999) (Fig. 6). If the chimpanzee did not
ecome infected, the same transfection was repeated
nce. After two negative results, the next clone was
noculated into the same chimpanzee following the same
rotocol. Injections were performed at weeks 0 and 2
ith pH77CV-J6S, at weeks 5 and 8 with pH77(p7)CV-J6S,
t weeks 14 and 16 with pH77-J6S, at weeks 19 and 23
ith pH77(p7)-J6S, at week 28 with pJ6CF, and finally at
eek 34 with pCV-H77C. The chimpanzee was main-
ained under conditions that met or exceeded all require-
ents for its use in an approved facility.
Serum samples were collected weekly from the chim-
anzee and monitored for liver enzyme levels by stan-
ard procedures, anti-HCV antibodies by the second-
eneration ELISA (Abbott), and HCV RNA by a sensitive
T-nested PCR assay with AmpliTaq Gold DNA polymer-
se using primers from the 59 UTR (Yanagi et al., 1996).
amples were scored as negative for HCV RNA if two
ndependent tests on 100 ml of serum were negative. The
E titer of HCV in positive samples was determined by
T-nested PCR on 10-fold serial dilutions of the extracted
NA (Bukh et al., 1998). The consensus sequence of the
omplete ORF from the chimpanzee infected with RNA
ranscripts of pJ6CF was determined by direct sequenc-
ng of overlapping PCR products obtained by long RT-
ested PCR as previously described (Yanagi et al., 1997)
ith HC-J6 specific primers. After the intrahepatic trans-
ection with RNA transcripts of pCV-H77C, we performed
77(genotype 1a)-specific RT-nested PCR with primers
427S-H77 and 2832R-H77 for the first round and with
rimers 2462S-H77 and 2645R-H77 for the second round
Table 3) and J6 (genotype 2a)-specific RT-nested PCR
ith primers 2439S-J6 and 2844R-J6 for the first round
nd with primers 2474S-J6 and 2657R-J6 for the second
ound (Table 3). The sensitivity of these genotype-spe-
ific RT-PCR assays was equivalent to that of the assay
sing 59 UTR primers when testing serum containing
nly H77, genotype 1a or only J6, genotype 2a, respec-ively. Mixing experiments using serum with known H77
1a) and J6 (2a) titers revealed that titers in a mixed
nfection were estimated correctly by these genotype-
pecific assays. The genome titers of genotypes 1a and
a were determined by using these specific RT-nested
CR assays on 10-fold serial dilutions of the extracted
NA. In HCV RNA-positive samples the total genome
iter was determined also by Amplicor HCV Monitor 2.0
Roche Diagnostic Systems, Branchburg, NJ) using prim-
rs that did not distinguish between the two genotypes.
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